Daptomycin
Links shared publicly online about this topic
Infectious Disease Article | Daptomycin
mdlinx.com — “Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With Suspected or Proved Gram-positive Infections” View full resource at mdlinx.com
Most Recently Shared on August 2, 2011 at 11:54 am By:
Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With... http://bit.ly/mShv7Q #ID
IngentaConnect Daptomycin and the risk of eosinophilic pneumonia
ingentaconnect.com — “IngentaConnect Daptomycin and the risk of eosinophilic pneumonia” View full resource at ingentaconnect.com
Most Recently Shared on August 13, 2010 at 10:49 am By:
Daptomycin and the risk of eosinophilic pneumonia: (Source: Reactions)MedWorm Message: Register for MedMatcha, Med... http://bit.ly/9ofa9b
ingentaconnect Daptomycin: Organising pneumonia and pneumothorax: case report
ingentaconnect.com — “ingentaconnect Daptomycin: Organising pneumonia and pneumothorax: case report” View full resource at ingentaconnect.com
Most Recently Shared on December 1, 2010 at 3:06 pm By:
Daptomycin: Organising pneumonia and pneumothorax: case report: (Source: Reactions)MedWorm Sponsor Message: Watc... http://bit.ly/e6Qvoz
FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
drugs.com — “FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 2:34 am By:
FDA Alert - FDA Warns of Eosinophilic Pneumonia Risk with Cubicin (daptomycin) - http://bit.ly/d3yDrx
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
fda.gov — “Cases of serious, potentially fatal pneumonia associated with the IV antibacterial drug Cubicin.” View full resource at fda.gov
Most Recently Shared on July 30, 2010 at 11:40 am By:
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia: Cases of serious, potentially ... http://bit.ly/bTeVBr
News Article : Eosinophilic Pneumonia Can Occur During Daptomycin Therapy
ashp.org — “News Article : Eosinophilic Pneumonia Can Occur During Daptomycin Therapy” View full resource at ashp.org
Most Recently Shared on July 30, 2010 at 12:00 am By:
Eosinophilic Pneumonia Can Occur During Daptomycin Therapy http://bit.ly/aASsUn via @YoTwits
Successful Treatment of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bacteremia with the Addition of Rifampin to Daptomycin (May) -- Ahmad and Rojtman, 10.1345/aph.1M665 -- The Annals of Pharmacotherapy
theannals.com — “Successful Treatment of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bacteremia with the Addition of Rifampin to Daptomycin (May) -- Ahmad and Rojtman, 10.1345/aph.1M665 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on March 31, 2010 at 2:53 am By:
Successful Treatment of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bacteremia with the ... http://bit.ly/9kOoqU
Medical News: FDA Finds Pneumonia Risk with Daptomycin - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The FDA said that the intravenous antibiotic daptomycin (Cubicin) may be linked to an increased risk of eosinophilic pneumonia -- a rare but serious potential side effect -- and requested that a new d” View full resource at medpagetoday.com
Most Recently Shared on July 29, 2010 at 5:41 pm By:
FDA Finds Pneumonia Risk with Daptomycin (MedPage Today) -- The FDA said that the intravenous antibiotic daptomycin (Cu.. http://dld.bz/ppsG
TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient
theannals.com — “TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient” View full resource at theannals.com
Most Recently Shared on July 21, 2011 at 7:15 pm By:
TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient: OBJECTIVE: To desc... http://bit.ly/pRvNCd
Journal of Medical Case Reports | Full text | Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature
jmedicalcasereports.com — “Journal of Medical Case Reports | Full text | Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature” View full resource at jmedicalcasereports.com
Most Recently Shared on March 25, 2011 at 10:48 pm By:
Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature. http://bit.ly/hhJWYR
FDA: Eosinophilic pneumonia may be linked to daptomycin use | HemOncToday
hemonctoday.com — “The FDA has issued a drug safety communication about the potential for developing eosinophilic pneumonia while being treated with daptomycin,” View full resource at hemonctoday.com
Most Recently Shared on July 30, 2010 at 4:18 pm By:
#FDA: Eosinophilic pneumonia may be linked to daptomycin use http://ht.ly/2iUgs
Two-Steps to Daptomycin Resistance (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The development of resistance to the antibiotic daptomycin (Cubicin) in some gut bacteria appears to be a two-step process, researchers reported.” View full resource at qualitypointtech.net
Most Recently Shared on September 8, 2011 at 7:45 pm By:
Two-Steps to Daptomycin Resistance (CME/CE): (MedPage Today) -- The development of resistance to the antibiotic da... http://t.co/mgNNTxd
Genetic basis for in vivo daptomycin resistance... [N Engl J Med. 2011] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on September 11, 2011 at 8:05 am By:
Genetic basis for in vivo daptomycin resistance in enterococci. http://t.co/AARtgrT #medicine
FDA MedWatch - Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia - Drugs.com MedNews
drugs.com — “ROCKVILLE, Md., July 29, 2010-ISSUE FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatmen” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 11:39 am By:
FDA MedWatch - Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia: ROCKVILLE, Md., J... http://bit.ly/b9uuaB
Use of Daptomycin in a Pregnant Patient with Staphylococcus aureus Endocarditis (April) -- Stroup et al., 10.1345/aph.1M650 -- The Annals of Pharmacotherapy
theannals.com — “Use of Daptomycin in a Pregnant Patient with Staphylococcus aureus Endocarditis (April) -- Stroup et al., 10.1345/aph.1M650 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on March 3, 2010 at 3:27 am By:
Use of Daptomycin in a Pregnant Patient with Staphylococcus aureus Endocarditis (April): OBJECTIVE... http://bit.ly/anZQ74
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Lungs and Breathing
Organizing lung and breathing resources shared by health experts, advocates, and organizations into WisdomCards.
-
Lungs and Breathing
Organizing lung and breathing resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement

